Elafibranor in the second-line treatment of primary biliary cholangitis
Review articleGastroent Hepatol 2025; 79(2): 94–101. doi: 10.48095/ccgh202594
SummaryLiteraturepdf Soňa FraňkováGastroent Hepatol 2025; 79(2): 94–101. doi: 10.48095/ccgh202594
SummaryLiteraturepdf Soňa Fraňková